Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Quimi Daphne Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2023 4 Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Granted 44,000 options to buy @ $3.19, valued at $140.4k
06/12/2023 4 Quimi Daphne (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Granted 16,985 options to buy @ $26.25, valued at $445.9k
01/19/2023 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 5,000 shares @ $12.4889, valued at $62.4k
Sold 6,923 shares @ $13, valued at $90k
01/13/2023 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 58,824 shares @ $0
Paid exercise price by delivering 29,565 shares @ $12.02, valued at $355.4k
01/06/2023 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 3,884 shares @ $12.03, valued at $46.7k
01/04/2023 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 15,165 shares @ $12.21, valued at $185.2k
Granted 73,508 shares @ $0
Paid exercise price by delivering 8,575 shares @ $11.93, valued at $102.3k
Granted 130,480 options to buy @ $11.93, valued at $1.6M
10/03/2022 4 Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Granted 39,744 options to buy @ $9.89, valued at $393.1k
09/06/2022 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 4,397 shares @ $11.2851, valued at $49.6k
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2022 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 36,840 shares @ $0
Paid exercise price by delivering 18,843 shares @ $10.53, valued at $198.4k
01/10/2022 4 Quimi Daphne (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Granted 8,400 options to buy @ $19, valued at $159.6k
01/04/2022 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 10,502 shares @ $11.55, valued at $121.3k
Paid exercise price by delivering 15,778 shares @ $11.55, valued at $182.2k
Paid exercise price by delivering 1,538 shares @ $12.11, valued at $18.6k
Granted 73,136 shares @ $0
Paid exercise price by delivering 4,041 shares @ $12.48, valued at $50.4k
Granted 134,044 options to buy @ $12.11, valued at $1.6M
04/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 5,000 shares @ $24.0947, valued at $120.5k
Exercised 5,000 options to buy @ $2.94, valued at $14.7k
12/17/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 4,156 shares @ $23.86, valued at $99.2k
Exercised 11,500 options to buy @ $2.94, valued at $33.8k
Exercised 7,550 options to buy @ $4.38, valued at $33.1k
Exercised 4,379 options to buy @ $3.53, valued at $15.5k
Exercised 6,892 options to buy @ $2.45, valued at $16.9k
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,046 shares @ $11.14, valued at $11.7k
04/03/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 4,803 shares @ $0
01/14/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 24,496 shares @ $0
Paid exercise price by delivering 12,065 shares @ $9.46, valued at $114.1k
01/10/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 15,000 shares @ $9.9301, valued at $149k
Exercised 9,822 options to buy @ $2.52, valued at $24.8k
Exercised 1,200 options to buy @ $4.38, valued at $5.3k
01/06/2020 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 7,113 shares @ $9.55, valued at $67.9k
Paid exercise price by delivering 5,305 shares @ $9.18, valued at $48.7k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2019 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,046 shares @ $11.35, valued at $11.9k
04/15/2019 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 12,347 shares @ $0
01/10/2019 4 Quimi Daphne (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 57,471 shares @ $0
Paid exercise price by delivering 3,850 shares @ $10.33, valued at $39.8k
Granted 88,154 options to buy @ $10.04, valued at $885.1k
03/12/2018 4 Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns: Sold 8,750 shares @ $15, valued at $131.3k
Exercised 8,750 options to buy @ $5.96, valued at $52.2k
03/05/2018 4 Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns: Sold 8,149 shares @ $14.0553, valued at $114.5k
Exercised 8,149 options to buy @ $4.16, valued at $33.9k
01/05/2018 4 Quimi Daphne (SVP, Finance) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns: Granted 12,609 shares @ $0
Paid exercise price by delivering 2,953 shares @ $15.67, valued at $46.3k
Granted 18,224 options to buy @ $15.67, valued at $285.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy